Search

Search Constraints

You searched for: Author/Creator Glosli, Heidi

Search Results

1. Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols. Issue 6 (24th November 2016)

2. Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial. Issue 8 (August 2018)

3. Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study. (August 2022)

4. Cardiac function in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO‐AML study. (7th October 2015)

5. Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial. Issue 1 (January 2021)

6. Fusion status in patients with lymph node‐positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Issue 15 (24th May 2018)

7. Hearing Status in Survivors of Childhood Acute Myeloid Leukemia Treated With Chemotherapy Only: A NOPHO-AML Study. Issue 1 (January 2019)

8. Hyperleucocytosis in paediatric acute myeloid leukaemia – the challenge of white blood cell counts above 200 × 109/l. The NOPHO experience 1984–2014. (25th May 2017)

9. Informed consent and assent guide for paediatric clinical trials in Europe. Issue 6 (1st December 2021)